The Johnson & Johnson, GlaxoSmithKline and DaVita HealthCare Partners-backed medical device producer is looking to raise $75m in an offering on the Nasdaq Global Market.
CVRx, a US-based medical device maker backed by medical products group Johnson & Johnson, pharmaceutical firm GlaxoSmithKline and healthcare provider DaVita HealthCare Partners, has filed to raise $75m in an initial public offering.
Founded in 2001, CVRx has developed an implantable medical device called Barostim Neo which is designed to treat heart failure in patients with cardiovascular diseases. It plans to use the IPO proceeds to expand its direct sales team and support research and development activities.
Strategic Healthcare…
